Literature DB >> 17990982

T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain.

Ana Lucia Giannini1, Yifang Gao, Marie-José Bijlmakers.   

Abstract

The recently identified RNF125 [RING (really interesting new gene) finger protein 125], or TRAC-1 (T-cell RING protein in activation 1), is unique among ubiquitin ligases in being a positive regulator of T-cell activation. In addition, TRAC-1 has been shown to down-modulate HIV replication and to inhibit pathogen-induced cytokine production. However, apart from the presence of an N-terminal C3HC4 (Cys(3)-His-Cys(4)) RING domain, the TRAC-1 protein remains uncharacterized. In the present paper, we report novel interactions and modifications for TRAC-1, and elucidate its domain organization. Specifically, we determine that TRAC-1 associates with membranes and is excluded from the nucleus through myristoylation. Our data are further consistent with a crucial role for the C-terminus in TRAC-1 function. In this region, novel domains were recognized through the identification of three closely related proteins: RNF114, RNF138 and RNF166. TRAC-1 and its relatives were found to contain, apart from the RING domain, a C2HC (Cys(2)-His-Cys)- and two C2H2 (Cys(2)-His(2))-type zinc fingers, as well as a UIM (ubiquitin-interacting motif). The UIM of TRAC-1 binds Lys(48)-linked polyubiquitin chains and is, together with the RING domain, required for auto-ubiquitination. As a consequence of auto-ubiquitination, the half-life of TRAC-1 is shorter than 30 min. The identification of these novel modifications, interactions, domains and relatives significantly widens the contexts for investigating TRAC-1 activity and regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17990982      PMCID: PMC2733222          DOI: 10.1042/BJ20070995

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Ubiquitin-mediated proteolysis: biological regulation via destruction.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Three classes of C2H2 zinc finger proteins.

Authors:  S Iuchi
Journal:  Cell Mol Life Sci       Date:  2001-04       Impact factor: 9.261

4.  A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation.

Authors:  Haoran Zhao; Connie C Li; Jorge Pardo; Peter C Chu; Charlene X Liao; Jianing Huang; John G Dong; Xiulan Zhou; Qi Huang; Betty Huang; Mark K Bennett; Susan M Molineaux; Henry Lu; Sarkiz Daniel-Issakani; Donald G Payan; Esteban S Masuda
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

5.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

6.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice.

Authors:  W L Perry; C M Hustad; D A Swing; T N O'Sullivan; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

7.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

8.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.

Authors:  Carola G Vinuesa; Matthew C Cook; Constanza Angelucci; Vicki Athanasopoulos; Lixin Rui; Kim M Hill; Di Yu; Heather Domaschenz; Belinda Whittle; Teresa Lambe; Ian S Roberts; Richard R Copley; John I Bell; Richard J Cornall; Christopher C Goodnow
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

9.  The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells.

Authors:  Sanae Shoji-Kawata; Qiu Zhong; Masanori Kameoka; Yukie Iwabu; Sompong Sapsutthipas; Ronald B Luftig; Kazuyoshi Ikuta
Journal:  Virology       Date:  2007-07-23       Impact factor: 3.616

10.  Systematic identification of regulatory proteins critical for T-cell activation.

Authors:  Peter Chu; Jorge Pardo; Haoran Zhao; Connie C Li; Erlina Pali; Mary M Shen; Kunbin Qu; Simon X Yu; Betty Cb Huang; Peiwen Yu; Esteban S Masuda; Susan M Molineaux; Frank Kolbinger; Gregorio Aversa; Jan de Vries; Donald G Payan; X Charlene Liao
Journal:  J Biol       Date:  2003-09-15
View more
  27 in total

1.  Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles.

Authors:  Dorota A Kedziorek; Naser Muja; Piotr Walczak; Jesus Ruiz-Cabello; Assaf A Gilad; Chunfa C Jie; Jeff W M Bulte
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

2.  The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice.

Authors:  Ismail Hassan Ismail; Jean-Philippe Gagné; Marie-Michelle Genois; Hilmar Strickfaden; Darin McDonald; Zhizhong Xu; Guy G Poirier; Jean-Yves Masson; Michael J Hendzel
Journal:  Nat Cell Biol       Date:  2015-10-26       Impact factor: 28.824

3.  The E3 ubiquitin ligase RNF114 and TAB1 degradation are required for maternal-to-zygotic transition.

Authors:  Ye Yang; Cheng Zhou; Ying Wang; Weixiao Liu; Chao Liu; Liying Wang; Yujiao Liu; Yongliang Shang; Mingrui Li; Shuai Zhou; Yuanting Wang; Wentao Zeng; Jianli Zhou; Ran Huo; Wei Li
Journal:  EMBO Rep       Date:  2017-01-10       Impact factor: 8.807

4.  RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.

Authors:  Yalan Lu; Deqiang Han; Wenjie Liu; Rong Huang; Jinhuan Ou; Xiaoqiao Chen; Xizhe Zhang; Xuezhi Wang; Shijun Li; Lin Wang; Changzheng Liu; Shiying Miao; Linfang Wang; Changwu Ma; Wei Song
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

5.  Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis.

Authors:  Marie-José Bijlmakers; Seshu K Kanneganti; Jonathan N Barker; Richard C Trembath; Francesca Capon
Journal:  Hum Mol Genet       Date:  2011-05-13       Impact factor: 6.150

6.  RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity.

Authors:  Brian D Yard; Nicole M Reilly; Michael K Bedenbaugh; Douglas L Pittman
Journal:  DNA Repair (Amst)       Date:  2016-04-21

Review 7.  Emerging role of ubiquitination in antiviral RIG-I signaling.

Authors:  Jonathan Maelfait; Rudi Beyaert
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

8.  ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.).

Authors:  J Han; Y-L Kim; K-W Lee; N-G Her; T-K Ha; S Yoon; S-I Jeong; J-H Lee; M-J Kang; M-G Lee; B-K Ryu; J-H Baik; S-G Chi
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

Review 9.  The influence of interferon on healthy and diseased skin.

Authors:  Grace A Hile; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Cytokine       Date:  2018-12-06       Impact factor: 3.861

10.  Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene.

Authors:  Francesca Capon; Marie-José Bijlmakers; Natalie Wolf; Maria Quaranta; Ulrike Huffmeier; Michael Allen; Kirsten Timms; Victor Abkevich; Alexander Gutin; Rhodri Smith; Richard B Warren; Helen S Young; Jane Worthington; A David Burden; Christopher E M Griffiths; Adrian Hayday; Frank O Nestle; Andre Reis; Jerry Lanchbury; Jonathan N Barker; Richard C Trembath
Journal:  Hum Mol Genet       Date:  2008-03-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.